| Application number | Title of the application | Filing Date | Status |
|---|
| 09/290846 | HEMOSTATIC POLYMER USEFUL FOR RAPID BLOOD COAGULATION AND HEMOSTASIS | Apr 12, 1999 | Abandoned |
Array
(
[id] => 4415660
[patent_doc_number] => 06194137
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Method of cryopreservation of blood vessels by vitrification'
[patent_app_type] => 1
[patent_app_number] => 9/289977
[patent_app_country] => US
[patent_app_date] => 1999-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 7175
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194137.pdf
[firstpage_image] =>[orig_patent_app_number] => 289977
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/289977 | Method of cryopreservation of blood vessels by vitrification | Apr 12, 1999 | Issued |
Array
(
[id] => 4274261
[patent_doc_number] => 06281003
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Enzymatic synthesis of optically active hydroxamic acids and their conversion to optically active primary amines by a lossen rearrangement'
[patent_app_type] => 1
[patent_app_number] => 9/180747
[patent_app_country] => US
[patent_app_date] => 1999-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6937
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281003.pdf
[firstpage_image] =>[orig_patent_app_number] => 180747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/180747 | Enzymatic synthesis of optically active hydroxamic acids and their conversion to optically active primary amines by a lossen rearrangement | Apr 4, 1999 | Issued |
| 09/268405 | RED BLOOD CELL STORAGE SOLUTION | Mar 14, 1999 | Abandoned |
| 09/171053 | STORAGE OF MATERIALS | Mar 14, 1999 | Abandoned |
Array
(
[id] => 4085702
[patent_doc_number] => 06133018
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Enzymatic synthesis of chiral amines using -2-amino propane as amine donor'
[patent_app_type] => 1
[patent_app_number] => 9/266100
[patent_app_country] => US
[patent_app_date] => 1999-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2739
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133018.pdf
[firstpage_image] =>[orig_patent_app_number] => 266100
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/266100 | Enzymatic synthesis of chiral amines using -2-amino propane as amine donor | Mar 9, 1999 | Issued |
Array
(
[id] => 6095623
[patent_doc_number] => 20020051963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'SHELF PRESERVATION OF CELLS, TISSUES, ORGANS AND ORGANISMS BY VITRIFICATION'
[patent_app_type] => new
[patent_app_number] => 09/254563
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4366
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20020051963.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254563
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254563 | SHELF PRESERVATION OF CELLS, TISSUES, ORGANS AND ORGANISMS BY VITRIFICATION | Mar 4, 1999 | Abandoned |
Array
(
[id] => 4266299
[patent_doc_number] => 06322785
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Methods and compositions for bone graft implants'
[patent_app_type] => 1
[patent_app_number] => 9/261291
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2893
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/322/06322785.pdf
[firstpage_image] =>[orig_patent_app_number] => 261291
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/261291 | Methods and compositions for bone graft implants | Mar 1, 1999 | Issued |
Array
(
[id] => 4085446
[patent_doc_number] => 06133001
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone'
[patent_app_type] => 1
[patent_app_number] => 9/256029
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2494
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133001.pdf
[firstpage_image] =>[orig_patent_app_number] => 256029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/256029 | Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-fluorophenyl)propyl)]-4(S)-(4 -hydroxyphenyl)-2-azetidinone | Feb 22, 1999 | Issued |
Array
(
[id] => 4380027
[patent_doc_number] => 06277626
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Process for the enzymatic resolution of lactams'
[patent_app_type] => 1
[patent_app_number] => 9/250197
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277626.pdf
[firstpage_image] =>[orig_patent_app_number] => 250197
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/250197 | Process for the enzymatic resolution of lactams | Feb 15, 1999 | Issued |
Array
(
[id] => 4351514
[patent_doc_number] => 06218099
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Methods and compositions for use in perfusion applications'
[patent_app_type] => 1
[patent_app_number] => 9/244283
[patent_app_country] => US
[patent_app_date] => 1999-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8961
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218099.pdf
[firstpage_image] =>[orig_patent_app_number] => 244283
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/244283 | Methods and compositions for use in perfusion applications | Feb 2, 1999 | Issued |
Array
(
[id] => 4187635
[patent_doc_number] => 06153432
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Methods for the differentiation of human preadipocytes into adipocytes'
[patent_app_type] => 1
[patent_app_number] => 9/240029
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 7880
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153432.pdf
[firstpage_image] =>[orig_patent_app_number] => 240029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/240029 | Methods for the differentiation of human preadipocytes into adipocytes | Jan 28, 1999 | Issued |
Array
(
[id] => 6129727
[patent_doc_number] => 20020076782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'PURIFIED NITRIC OXIDE SYNTHASE'
[patent_app_type] => new
[patent_app_number] => 09/225426
[patent_app_country] => US
[patent_app_date] => 1999-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15459
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076782.pdf
[firstpage_image] =>[orig_patent_app_number] => 09225426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225426 | PURIFIED NITRIC OXIDE SYNTHASE | Jan 4, 1999 | Abandoned |
Array
(
[id] => 4083149
[patent_doc_number] => 06162637
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-19
[patent_title] => 'Aspergillus niger which produces vanillic acid from ferulic acid'
[patent_app_type] => 1
[patent_app_number] => 9/216031
[patent_app_country] => US
[patent_app_date] => 1998-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4469
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/162/06162637.pdf
[firstpage_image] =>[orig_patent_app_number] => 216031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/216031 | Aspergillus niger which produces vanillic acid from ferulic acid | Dec 17, 1998 | Issued |
Array
(
[id] => 4378884
[patent_doc_number] => 06277556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Controlling donor blood characteristics'
[patent_app_type] => 1
[patent_app_number] => 9/213214
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5172
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277556.pdf
[firstpage_image] =>[orig_patent_app_number] => 213214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/213214 | Controlling donor blood characteristics | Dec 16, 1998 | Issued |
Array
(
[id] => 4244902
[patent_doc_number] => 06136591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'Bioresolution of N-acylazetidine-2-carboxylic acids'
[patent_app_type] => 1
[patent_app_number] => 9/202431
[patent_app_country] => US
[patent_app_date] => 1998-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4412
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136591.pdf
[firstpage_image] =>[orig_patent_app_number] => 202431
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202431 | Bioresolution of N-acylazetidine-2-carboxylic acids | Dec 14, 1998 | Issued |
Array
(
[id] => 1596994
[patent_doc_number] => 06492494
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Method of making a fibrin sealant comprising alpha-2-antiplasmin'
[patent_app_type] => B1
[patent_app_number] => 09/208352
[patent_app_country] => US
[patent_app_date] => 1998-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6418
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09208352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/208352 | Method of making a fibrin sealant comprising alpha-2-antiplasmin | Dec 8, 1998 | Issued |
| 09/199541 | ORGAN PRESERVATION SOLUTION CONTAINING PYRUVATE | Nov 24, 1998 | Abandoned |
| 09/200023 | COMPRISING AN AMMONIUM SALT | Nov 24, 1998 | Abandoned |
Array
(
[id] => 1588282
[patent_doc_number] => 06482584
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Cyclic implant perfusion cleaning and passivation process'
[patent_app_type] => B1
[patent_app_number] => 09/191232
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9054
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482584.pdf
[firstpage_image] =>[orig_patent_app_number] => 09191232
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191232 | Cyclic implant perfusion cleaning and passivation process | Nov 12, 1998 | Issued |